Gene Query: MYO18A

Dataset Description Geneva Score
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 122.84
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 68.7
Identification of Nrf2 regulated genes by RNA sequencing 57.29
Nrf2 regulated genes in A549 cells 57.29
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 56.15
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 52.56
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 51.28
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 48.2
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 48.2
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  46.81
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 45.51
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 44.29
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 43.59
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 43.59
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 41.89
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 39.7
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 39.7
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 36.68
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 32.91
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 31.94
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 31.94
Silencing SPIB in attached and floating state of H1703 lung cancer cells 31.83
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 31.3
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 29.83
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 29.21
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 29.21
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 28.79
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 28.7
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 28.63
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 28.63
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 28.14
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 26.92
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 26.28
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 26.21
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 25.69
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 25.65
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 25.59
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 25.46
GATA3-mediated chromatin reprogramming in breast cancer cells 24.93
Effect of Influenza virus infection on lncRNA expression in A549 cells 24.48
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 23.58
RNA-seq of MDA-MB-231 cells with TET1 knockout 23.42
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 23.23
DIGIT regulates endoderm differentiation of human embryonic stem cells 23.2
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 23.11
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 22.97
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 22.83
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 22.11
Functional role of SLIT2 and ROBO1 in trophoblasts 21.66
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 21.66
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 21.4
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 21.38
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 21.18
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 21.09
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 21.09
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 20.92
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 20.74
Control of prostate tumour growth by the long non-coding RNA GHSROS 20.32
Sensing self and nonself circular RNAs 19.97
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 19.85
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 19.71
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 19.69
CD73 knockdown effect in pancreatic cancer cell lines 19.69
RNA-seq of naive and primed ES cells (NHSM) 19.68
TCF7L1 knockdown in pancreatic cancer 19.48
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 19.38
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 19.31
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 19.18
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 19.01
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 19.0
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 18.79
Differential analysis of gene regulation at transcript resolution by RNA-Seq 18.79
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 18.76
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 18.75
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 18.56
ChIP-seq and RNA-seq from human lymphoma cell lines 18.49
RNA-seq data from human lymphoma cell lines 18.49
Patient-derived luminal breast cancer xenografts with progestins 18.47
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 18.47
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 18.32
circRNA-sequencing 18.3
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 18.28
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 18.19
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 18.03
Accurate annotation of human protein-coding small open reading frames 17.93
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 17.82
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 17.65
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 17.54
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 17.53
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 17.35
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 17.35
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 17.18
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 17.18
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 17.17
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 17.03
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 17.03
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 17.02
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 17.02
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 16.9
RNA-seq analyisis of PUM2 knockout cells 16.72
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 16.63
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 16.61
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 16.56
Loss of CREBBP results in gene expression repression in lymphoma cells 16.56
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 16.41
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 16.29
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 16.24
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 16.21
Hepatitis C virus functionally sequesters miR-122 16.2
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 16.2
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 16.07
Regulation of hypoxia-inducible factor activity by ZMYND8 15.99
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 15.94
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 15.92
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 15.92
RNA-sequencing in irradiated and normal A549 cells. 15.84
A sister of NANOG regulates genes expressed in pre-implantation human development 15.73
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 15.67
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 15.6
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 15.52
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 15.5
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 15.41
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 15.41
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 15.21
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 15.2
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 15.13
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 15.08
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 14.96
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 14.94
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 14.91
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 14.81
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 14.81
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 14.75
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 14.65
Primary Human B-cell Temporal Response to CD40L Stimulation 14.64
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 14.64
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 14.59
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 14.5
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 14.48
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 14.42
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 14.21
MOF acetyl transferase regulates transcription and respiration in mitochondria 14.14
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 14.12
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 14.0
Real-time observation of light-controlled transcription in living cells 13.96
IL-33 activates tumor stroma to promote intestinal polyposis 13.9
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 13.79
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 13.78
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 13.77
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 13.76
Genome wide expression change by RNF168 knocking down in NEC cells 13.67
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 13.56
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 13.55
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 13.51
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 13.48
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 13.44
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 13.37
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 13.33
MYCi975 regulates MYC target genes 13.32
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 13.26
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 13.24
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 13.14
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 13.14
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 13.07
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 13.05
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 12.99
Ebola virus (EBOV) infection of ARPE-19 cells 12.87
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 12.83
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 12.79
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 12.79
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 12.74
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 12.73
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 12.71
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 12.69
hTERT promotes cell adhesion and migration independent of telomerase activity 12.66
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 12.26
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 12.23
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 12.22
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 12.21
RNA-seq differential expression studies: more sequence, or more replication? 12.2
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 12.17
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 12.15
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 12.09
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 12.05
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 12.04
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 12.01
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 11.96
Global analyses of the effect of different cellular contexts on microRNA targeting 11.96
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 11.93
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 11.93
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 11.92
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 11.91
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 11.87
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 11.87
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 11.83
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 11.77
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 11.75
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 11.64
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 11.62
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 11.62
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 11.61
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 11.61
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 11.58
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 11.53
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 11.39
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 11.38
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 11.32
The human blood-nerve barrier transcriptome 11.26
Lysine benzoylation is a novel histone mark [RNA-seq] 11.26
Lysine benzoylation is a novel histone mark 11.26
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 11.25
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 11.25
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 11.25
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 11.24
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 11.18
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 11.13
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 11.12
Differential Gene Expression between MCF10A and MCF7 cells 11.05
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 11.03
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 11.0
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 10.93
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 10.9
Differential gene expression profiles in imatinib-resistant cell lines 10.89
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 10.89
RNA-seq analysis of BAP1-depleted uveal melanoma cells 10.77
Oncogenic MYC induces a dependency on the spliceosome in human cancer 10.75
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 10.74
Pharmacologic inhibition of STAT5 in AML 10.74
Disruption of the exocyst induces podocyte loss and dysfunction 10.72
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 10.67
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 10.66
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 10.66
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 10.62
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 10.57
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 10.57
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 10.56
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 10.55
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 10.53
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 10.51
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 10.51
The transcriptome and chromatin accessbility landscape of mammalian germline 10.44
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 10.42
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 10.42
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 10.42
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 10.38
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 10.33
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 10.33
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 10.3
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 10.29
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 10.29
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 10.27
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 10.26
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 10.22
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 10.22
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 10.19
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 10.17
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 10.14
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 10.1
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 10.02
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 9.91
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 9.83
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 9.83
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 9.8
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 9.8
Transcriptome-wide response to synthetic chromatin protein PcTF 9.8
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 9.75
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 9.71
Tpl-2 and MEK small molecule inhibitors 9.7
Tpl-2 small molecule project 9.7
Identification of Atrial Fibrillation associated genes and functional non-coding variants 9.65
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 9.62
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 9.58
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 9.57
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 9.57
Crizotinib v. DMSO in SW480 cells 9.54
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 9.51
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 9.5
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 9.5
Targeted enhancer activation by a subunit of the integrator complex 9.46
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 9.45
RNAseq Study in CC-671 Treated Cal-51 Cells 9.4
Intrahepatic MAIT cell gene expression revealed by RNA-seq 9.26
circRNA-sequencing 9.25
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 9.25
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 9.25
RNA seq comparison between scrambled and shGRP78 cells 9.23
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 9.18
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 9.18
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 9.15
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 9.15
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 9.06
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 9.04
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 9.04
ARS2 is a general suppressor of pervasive transcription [RNAseq] 9.04
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 8.87
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 8.87
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 8.83
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 8.83
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 8.83
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 8.79
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 8.72
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 8.71
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 8.69
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 8.63
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 8.61
Genome-wide analysis of Dengue virus 2 infected cells 8.56
Intron retention induced by microsatellite expansions as a disease biomarker. 8.51
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 8.51
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 8.45
Generation and functional characterization of MDSC-like cells 8.45
Genome-wide identification of cancer-specific alternative splicing in circRNA 8.44
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 8.41
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 8.41
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 8.4
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 8.33
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 8.33
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 8.3
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 8.26
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 8.25
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 8.25
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 8.22
Gene expression profiling of human and murine in vitro muscle differentiation 8.21
Genetic-to-epigenetic Therapy for Pancreatic Cancer 8.14
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 8.09
CSL 7.95
CSL RNA-Seq on HKC and SCC cell lines 7.95
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 7.83
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 7.83
Metabolism as an early predictor of DPSCs aging 7.82
RNA sequencing of mechanically strained NHEKs and control NHEKs 7.74
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 7.67
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 7.67
Random mono-allelic expression in MECP2-mutated cells 7.55
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 7.48
Searching for target genes of miR-508/509/506/514 in HCT116 cells 7.42
UV_24h_GRO-Seq 7.27
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 7.27
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 7.24
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 7.13
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 7.12
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 7.05
Hypoxic transcriptome of SQ20B human head and neck cancer cells 7.04
Aneuploidy triggers an immune response 6.9
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 6.86
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 6.86
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 6.83
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 6.83
Downregulation of DDX5/DDX17 and REST 6.62
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 6.62
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 6.58
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 6.54
A Unique Epigenomic Landscape Defines Human Erythropoiesis 6.54
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 6.54
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 6.54
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 6.51
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 6.51
Identification of Sin3B regulated genes during quiescence 6.48
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 6.46
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 6.43
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 6.36
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 6.17
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 6.14
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 6.05
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 6.05
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 6.05
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 6.02
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 5.99
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 5.76
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 5.67
Widespread regulated alternative splicing of single codons accelerates proteome evolution 5.61
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 5.56
The transcriptome of Kawasaki Disease arteritis 5.5
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 5.4
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 5.28
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 5.26
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 5.19
The cytokine environment influence on human skin-derived T cells 5.18
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  5.11
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 5.03
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 4.93
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 4.93
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 4.9
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 4.89
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 4.87
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 4.77
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 4.77
Transcriptome of activated human and mouse MAIT cells 4.77
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 4.74
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 4.74
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 4.71
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 4.67
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 4.63
Expression profiling of converted and control dermal BJ fibroblasts 4.55
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 4.55
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 4.48
RNA-seq of cells with TET1 knockout 4.48
Human Tfh cell RNA bulk sequencing 4.46
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 4.37
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 4.32
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 4.27
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 4.23
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 4.21
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 4.21
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 4.19
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 4.13
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 4.13
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 4.11
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 4.1
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 4.07
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 3.99
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 3.97
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 3.96
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 3.96
Gene expression profile in breast cancer cells 3.94
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 3.94
SOX11 knockdown in B-ALL cell lines 3.87
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 3.78
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 3.77
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 3.77
Trascriptome of thyroid cancer-induced macrophages 3.67
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 3.41
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 3.33
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 3.32
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 3.13
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 2.9
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 2.9
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 2.85
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 2.85
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 2.84
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 2.8
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 2.66
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 2.63
Activity-dependent transcriptional changes in human neurons 2.56
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 2.5
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 2.34
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 2.31
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 2.25
K562 polyA RNA-Seq 2.23
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 2.22
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 2.22
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 2.14
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 2.11
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 2.11
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 2.11
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 2.08
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 2.04
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 2.04
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 2.04
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 1.85
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 1.84
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 1.83
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 1.82
Targeting MTHFD2 in Acute Myeloid Leukemia 1.7
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 1.67
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 1.64
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 1.62
Transcriptome analysis of CNS leukemia 1.62
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 1.57
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 1.35
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 1.29
Gene expression profile of CRC-derived HILEC 1.29
The pioneer factor CEBPA modulates vitamin D signaling 1.27
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 1.27
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.23
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.23
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 1.1
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 1.06
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 0.96
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.96
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.89
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.85
Energy Metabolism during Anchorage-Independence 0.83
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 0.83
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 0.82
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 0.79
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 0.79
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.76
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.73
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 0.73
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.7
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.68
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 0.62
Dermal endothelial cells of type 2 diabetic patients 0.58
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.57
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.5
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.49
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.46
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.46
RNA-seq of primary patient AML samples 0.44
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.44
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.44
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.42
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.42
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.36
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.24
EGR1-controlled transcriptome of T HESCs 0.22
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 0.21
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.14
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.11
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.07


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation